Dimensional Fund Advisors LP Sells 23,623 Shares of LifeVantage Co. (NASDAQ:LFVN)

Dimensional Fund Advisors LP cut its stake in shares of LifeVantage Co. (NASDAQ:LFVN - Free Report) by 8.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 272,748 shares of the company's stock after selling 23,623 shares during the quarter. Dimensional Fund Advisors LP owned approximately 2.17% of LifeVantage worth $4,782,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of LFVN. Copeland Capital Management LLC acquired a new position in LifeVantage during the 4th quarter worth about $65,000. Hillsdale Investment Management Inc. lifted its holdings in LifeVantage by 7.3% during the 4th quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company's stock worth $258,000 after buying an additional 1,000 shares during the period. Barclays PLC lifted its stake in shares of LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company's stock valued at $507,000 after purchasing an additional 11,608 shares during the period. Ritholtz Wealth Management lifted its stake in shares of LifeVantage by 65.2% in the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company's stock valued at $830,000 after purchasing an additional 18,682 shares during the period. Finally, EAM Investors LLC acquired a new position in shares of LifeVantage in the 4th quarter valued at about $1,056,000. 35.32% of the stock is owned by institutional investors and hedge funds.

LifeVantage Stock Performance

Shares of NASDAQ:LFVN traded up $0.78 during midday trading on Friday, reaching $13.39. The company's stock had a trading volume of 152,364 shares, compared to its average volume of 140,539. The firm has a market capitalization of $168.55 million, a price-to-earnings ratio of 23.91 and a beta of 0.41. The firm has a 50 day moving average price of $13.92 and a two-hundred day moving average price of $16.33. LifeVantage Co. has a fifty-two week low of $5.22 and a fifty-two week high of $27.38.

LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.10. The company had revenue of $58.44 million for the quarter, compared to the consensus estimate of $60.99 million. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be paid a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.34%. This is an increase from LifeVantage's previous quarterly dividend of $0.04. The ex-dividend date of this dividend is Friday, May 30th. LifeVantage's payout ratio is currently 26.09%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.